Endoscopy 2018; 50(04): 378-385
DOI: 10.1055/s-0043-122386
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Aggressive intravenous hydration with lactated Ringer’s solution for prevention of post-ERCP pancreatitis: a prospective randomized multicenter clinical trial

Chang-Hwan Park
1   Department of Internal Medicine, Chonnam National University Medical School, Gwangju, South Korea
,
Woo Hyun Paik
2   Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea
,
Eun Taek Park
3   Department of Internal Medicine, Gospel Hospital, University of Kosin College of Medicine, Busan, South Korea
,
Chan Sup Shim
4   Digestive Disease Center, Konkuk University School of Medicine, Seoul, South Korea
,
Tae Yoon Lee
4   Digestive Disease Center, Konkuk University School of Medicine, Seoul, South Korea
,
Changdon Kang
5   Department of Internal Medicine, School of Medicine, Kangwon National University, Kangwon, South Korea
,
Myung Hwan Noh
6   Department of Internal Medicine, Dong-A University College of Medicine, Busan, South Korea
,
Sun Youn Yi
7   Department of Internal Medicine, School of Medicine, Ewha Woman’s University, Seoul, South Korea
,
Jong Kyun Lee
8   Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
,
Jong Jin Hyun
9   Department of Medicine, Korea University Ansan Hospital, Seoul, South Korea
,
Jun Kyu Lee
10   Dongguk University Ilsan Hospital, Goyang, South Korea
› Author Affiliations
TRIAL REGISTRATION: Prospective Randomized Multi-Center Trial KCT0001398 at https://cris.nih.go.kr/cris
Further Information

Publication History

submitted 28 May 2017

accepted after revision 25 September 2017

Publication Date:
13 December 2017 (online)

Abstract

Background and study aims The present study aimed to determine the type of intravenous hydration that is best suited to reducing the incidence of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis.

Patients and methods In a prospective randomized multicenter trial, average-to-high risk patients who underwent first-time ERCP were randomly assigned to three groups (1:1:1) who received: aggressive intravenous hydration (3 mL/kg/h during ERCP, a 20-mL/kg bolus and 3 mL/kg/h for 8 hours after ERCP) with either lactated Ringer’s solution (LRS) or normal saline solution (NSS), or standard intravenous hydration with LRS (1.5 mL/kg/h during and for 8 hours after ERCP). The primary end point was post-ERCP pancreatitis (PEP).

Results 395 patients were enrolled, and 385 completed the protocols. The three groups showed no significant differences in demographic characteristics. There was a significant difference in the intention-to-treat (ITT) PEP rate between the aggressive LRS group (3.0 %, 95 % confidence interval [CI] 0.1 % – 5.9 %; 4 /132), the aggressive NSS group (6.7 %, 95 %CI 2.5 % – 10.9 %; 9 /134) and the standard LRS group (11.6 %, 95 %CI 6.1 % – 17.2 %; 15 /129; P = 0.03). In the two-group comparisons, the ITT PEP rate was significantly lower for the aggressive LRS group than for the standard LRS group (relative risk [RR] 0.26, 95 %CI 0.08 – 0.76; P = 0.008). There was no significant difference in the ITT PEP rate between the aggressive NSS group and the standard LRS group (RR 0.57, 95 %CI 0.26 – 1.27; P = 0.17).

Conclusion Aggressive hydration with LRS is the best approach to intravenous hydration for the prevention of PEP in average-to-high risk patients.

 
  • References

  • 1 Zhang ZF, Duan ZJ, Wang LX. et al. Aggressive hydration with lactated Ringer solution in prevention of postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. J Clin Gastroenterol 2017; 51: e17-e26
  • 2 Wang AY, Strand DS, Shami VM. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: medications and techniques. Clin Gastroenterol Hepatol 2016; 14: 1521-1532
  • 3 Inamdar S, Han D, Passi M. et al. Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis. Gastrointest Endosc 2017; 85: 67-75
  • 4 Shi N, Deng L, Altaf K. et al. Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials. Turk J Gastroenterol 2015; 26: 236-240
  • 5 Puig I, Calvet X, Baylina M. et al. How and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysis. PLoS One 2014; 9: e92922
  • 6 Li X, Tao LP, Wang CH. Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: a meta-analysis. World J Gastroenterol 2014; 20: 12322-12329
  • 7 Levenick JM, Gordon SR, Fadden LL. et al. Rectal indomethacin does not prevent post-ERCP pancreatitis in consecutive patients. Gastroenterology 2016; 150: 911-917
  • 8 Mazaki T, Mado K, Masuda H. et al. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol 2014; 49: 343-355
  • 9 Dumonceau JM, Andriulli A, Elmunzer BJ. et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – updated June 2014. Endoscopy 2014; 46: 799-815
  • 10 Ito K, Horaguchi J, Fujita N. et al. Clinical usefulness of double-guidewire technique for difficult biliary cannulation in endoscopic retrograde cholangiopancreatography. Dig Endosc 2014; 26: 442-449
  • 11 UK Working Party on Acute Pancreatitis. UK guidelines for the management of acute pancreatitis. Gut 2005; 54: iii1-iii9
  • 12 Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006; 101: 2379-2400
  • 13 Wu BU, Hwang JQ, Gardner TH. et al. Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol 2011; 9: 710-717.e1
  • 14 Buxbaum J, Yan A, Yeh K. et al. Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol 2014; 12: 303-307.e1
  • 15 Katsinelos P, Lazaraki G, Chatzimavroudis G. et al. Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist. Ann Gastroenterol 2014; 27: 65-72
  • 16 Ding X, Zhang F, Wang Y. Risk factors for post-ERCP pancreatitis: A systematic review and meta-analysis. Surgeon 2015; 13: 218-229
  • 17 Rustagi T, Jamidar PA. Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events: post-ERCP pancreatitis. Gastrointest Endosc Clin N Am 2015; 25: 107-121
  • 18 Elmunzer BJ, Scheiman JM, Lehman GA. et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. NEJM 2012; 366: 1414-1422
  • 19 Banks PA, Bollen TL, Dervenis C. et al. Classification of acute pancreatitis: 2012-revision of the Atlanta classification and definition by international consensus. Gut 2013; 62: 102-111
  • 20 Kusterer K, Enghofer M, Zendler S. et al. Microcirculatory changes in sodium taurocholate-induced pancreatitis in rats. Am J Physiol 1991; 260: G346-G351
  • 21 Muddana V, Whitecomb DC, Khalid A. et al. Elevated serum creatinine as a marker of pancreatic necrosis in acute pancreatitis. Am J Gastroenterol 2009; 104: 164-170
  • 22 Chen Y, Ma L, Song X. et al. Beneficial effects of fluid resuscitation via the rectum on hemodynamic disorders and multiple organ injuries in an experimental severe acute pancreatitis model. Pancreatology 2015; 15: 626-634
  • 23 Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 2013; 13: e1-e15
  • 24 Wu BU, Banks PA. Clinical management of patients with acute pancreatitis. Gastroenterology 2013; 14: 1272-1281
  • 25 Schepers NJ, Besselink MG, van Santvoort HC. et al. Early management of acute pancreatitis. Best Pract Res Clin Gastroenterol 2013; 27: 727-743
  • 26 Minkov GA, Halacheva KS, Yovtchev YP. et al. Pathophysiological mechanisms of acute pancreatitis define inflammatory markers of clinical prognosis. Pancreas 2015; 44: 713-717
  • 27 Noble MD, Romac J, Vigna SR. et al. A pH-sensitive, neurogenic pathway mediates disease severity in a model of post-ERCP pancreatitis. Gut 2008; 57: 1566-1571
  • 28 Bhoomagoud M, Jung T, Atladottir J. et al. Reducing extracellular pH sensitizes the acinar cell to secretagogue-induced pancreatitis responses in rats. Gastroenterology 2009; 137: 1083-1092
  • 29 Mok SR, Ho HC, Shah P. et al. Lactated Ringer's solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission: a prospective randomized, double-blinded, placebo-controlled trial. Gastrointest Endosc 2017; 85: 1005-1013